Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Benzydamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.97 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.97 |
| ▸ | GUCY1B2 | O75343 | 1/20 | 0.97 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.97 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.97 |
| ▸ | HTR1A | P08908 | 1/20 | 0.97 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.97 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.97 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.97 |
| ▸ | DRD1 | P21728 | 1/20 | 0.97 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.97 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.97 |
| ▸ | GUCY1A2 | P33402 | 1/20 | 0.97 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.97 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.97 |
| ▸ | DRD3 | P35462 | 1/20 | 0.97 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.97 |
| ▸ | GUCY1A1 | Q02108 | 1/20 | 0.97 |
| ▸ | GUCY1B1 | Q02153 | 1/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzydamine SCHEMBL42645 | 1.00 | POLB (1.00) | POLBHRH3KDM4EGUCY1B2CYP1A2 | |
| Benzydamine SCHEMBL29376229 | 0.99 | HRH3 (1.00) | POLBHRH3KDM4EGUCY1B2CYP1A2 | |
| Benzydamine SCHEMBL26172 | 0.99 | HRH3 (1.00) | POLBHRH3KDM4EGUCY1B2CYP1A2 | |
| Benzydamine SCHEMBL8078518 | 0.97 | HRH3 (0.97) | POLBHRH3KDM4EGUCY1B2CYP1A2 | |
| Benzydamine SCHEMBL1648787 | 0.96 | HRH3 (0.95) | POLBHRH3KDM4EGUCY1B2CYP1A2 | |
| SCHEMBL8018576 | 0.95 | KDM4E (0.93) | POLBHRH3KDM4EGUCY1B2CYP1A2 | |
| SCHEMBL9917397 | 0.92 | DRD1 (0.88) | POLBHRH3KDM4EGUCY1B2CYP1A2 | |
| SCHEMBL8810482 | 0.90 | HRH3 (0.84) | POLBHRH3KDM4EGUCY1B2CYP1A2 | |
| Benzydamine SCHEMBL7135139 | 0.90 | HRH3 (0.83) | POLBHRH3KDM4EGUCY1B2CYP1A2 | |
| Benzydamine SCHEMBL28223703 | 0.90 | HRH3 (0.83) | POLBHRH3KDM4EGUCY1B2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5553 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4626404-A1 | DERMAL THERMOSENSITIVE GEL FORMULATIONS FOR THE TREATMENT OF INFLAMMATION-RELATED EDEMA AND VARIOUS PAINS | Istanbul Medipol Universitesi Teknoloji Transfer Ofisi Anonim Sirketi (TR) | 2025-10-08 | — | — | EP | claimed |
| WO-2025132345-A1 | PHARMACEUTICAL COMPOSITION COMPRISING BENZYDAMINE HYDROCHLORIDE AND CETYLPYRIDINIUM CHLORIDE | KRKA, D.D., NOVO MESTO (SI) | 2025-06-26 | — | — | WO | claimed |
| US-20250154554-A1 | ANTIMICROBIAL SUSCEPTIBILITY | FASTINOV, SA (PT) | 2025-05-15 | — | — | US | claimed |
| EP-4476357-A1 | ANTIMICROBIAL SUSCEPTIBILITY | Fastinov S.A. (PT) | 2024-12-18 | — | — | EP | claimed |
| US-20240366537-A1 | THERAPEUTIC PATCH AND USES THEREOF | ORIPATCH AS (NO) | 2024-11-07 | — | — | US | claimed |
| CN-118900918-A | Antimicrobial drug sensitivity | 法斯丁诺夫股份公司 | 2024-11-05 | — | — | CN | claimed |
| US-20240200072-A1 | Allogeneic Cartilage Regeneration | Tarachon, LLC (US) | 2024-06-20 | — | — | US | claimed |
| WO-2024118019-A1 | DERMAL THERMOSENSITIVE GEL FORMULATIONS FOR THE TREATMENT OF INFLAMMATION-RELATED EDEMA AND VARIOUS PAINS | ISTANBUL MEDIPOL UNIVERSITESI TEKNOLOJI TRANSFER OFISI ANONIM SIRKETI (TR) | 2024-06-06 | — | — | WO | claimed |
| EP-4366694-A1 | THERAPEUTIC PATCH AND USES THEREOF | Oripatch AS (NO) | 2024-05-15 | — | — | EP | claimed |
| EP-4335413-A2 | PROSTHETIC TISSUE VALVES | Cormatrix Cardiovascular, Inc. (US) | 2024-03-13 | — | — | EP | claimed |
| EP-0901376-A1 | MALATONIN IN COMBINATION WITH ANALGESICS | Fuisz Technologies Ltd. (US) | 1999-03-17 | — | — | EP | claimed |
| WO-1998043630-A1 | MEANS OF ASCERTAINING AN INDIVIDUAL'S RISK PROFILE FOR ATHEROSCLEROTIC DISEASE | BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 1998-10-08 | — | — | WO | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| US-5700410-A | Method of manufacturing wax matrices | NIPPON SHINYAKU CO., LTD. (JP) | 1997-12-23 | — | — | US | claimed |
| EP-0812193-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING A BENZYDAMINE OR ITS SALT AND AN ANTIMICROBIAL AGENT | Smithkline Beecham Farmaceutici S.p.A. (IT) | 1997-12-17 | — | — | EP | claimed |
| WO-1997044045-A1 | MALATONIN IN COMBINATION WITH ANALGESICS | FUISZ TECHNOLOGIES LTD. (US) | 1997-11-27 | — | — | WO | claimed |
| EP-0580860-B1 | METHOD OF MANUFACTURING SOLID DISPERSION | NIPPON SHINYAKU CO LTD (JP) | 1997-10-22 | — | — | EP | claimed |
| WO-1996026724-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING A BENZYDAMINE OR ITS SALT AND AN ANTIMICROBIAL AGENT | SMITHKLINE BEECHAM S.P.A. (IT) | 1996-09-06 | — | — | WO | claimed |
| US-4749794-A | REMOVING 1-CHLORO-3-METHYLAMINOPROPANE IMPURITY FROM CRUDE PRODUCT | AZIENDE CHIMICHE RIUNUTE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 1988-06-07 | — | — | US | claimed |
| EP-0189861-A2 | Percutaneous absorption accelerator for ionic water-soluble medicine | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1986-08-06 | — | — | EP | claimed |